Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
Apple
AAPL
|
+$4.76B |
| 2 |
Microsoft
MSFT
|
+$1.4B |
| 3 |
NVIDIA
NVDA
|
+$1.4B |
| 4 |
Amazon
AMZN
|
+$1.22B |
| 5 |
Broadcom
AVGO
|
+$1.21B |
Top Sells
| 1 |
WRK
WestRock Company
WRK
|
+$316M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$181M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$150M |
| 4 |
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
|
+$139M |
| 5 |
Cadence Design Systems
CDNS
|
+$110M |
Sector Composition
| 1 | Technology | 31.06% |
| 2 | Financials | 12.83% |
| 3 | Healthcare | 11.53% |
| 4 | Consumer Discretionary | 10.45% |
| 5 | Industrials | 8.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
LAR
3876
Lithium Argentina AG
LAR
$498M
| $214K | ﹤0.01% |
65,252
+17,649
| +37% | +$57.8K |
|
3877
Nine Energy Service
NINE
$29.9M
| $214K | ﹤0.01% |
188,949
+23,742
| +14% | +$26.8K |
|
|
LUMO
3878
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $213K | ﹤0.01% |
55,148
+4,421
| +9% | +$17.1K |
|
|
BHAC
3879
DELISTED
Focus Impact BH3 Acquisition Company Class A Common Stock
BHAC
| $213K | ﹤0.01% |
20,185
-80
| -0.4% | -$844 |
|
3880
KALA BIO
KALA
$98.3M
| $212K | ﹤0.01% |
37,116
+18,225
| +96% | +$104K |
|
3881
VirnetX
VHC
$76.3M
| $211K | ﹤0.01% |
29,939
+1,662
| +6% | +$11.7K |
|
3882
POSCO
PKX
$15.4B
| $211K | ﹤0.01% |
3,016
-681
| -18% | -$47.7K |
|
3883
StealthGas
GASS
$277M
| $211K | ﹤0.01% |
30,948
| – | – |
|
|
SOWG
3884
Sow Good
SOWG
$9.16M
| $211K | ﹤0.01% |
18,013
-9,472
| -34% | -$111K |
|
3885
Tiziana Life Sciences
TLSA
$216M
| $210K | ﹤0.01% |
218,681
-840
| -0.4% | -$806 |
|
3886
Live Ventures
LIVE
$53.4M
| $210K | ﹤0.01% |
13,555
+330
| +2% | +$5.11K |
|
|
USBC
3887
USBC, Inc.
USBC
$287M
| $210K | ﹤0.01% |
18,286
+5,445
| +42% | +$62.4K |
|
3888
Stabilis Solutions
SLNG
$64.7M
| $209K | ﹤0.01% |
44,159
+3,429
| +8% | +$16.3K |
|
3889
Surrozen
SRZN
$100M
| $209K | ﹤0.01% |
17,761
-947
| -5% | -$11.1K |
|
3890
Aligos Therapeutics
ALGS
$78M
| $208K | ﹤0.01% |
24,056
+7,828
| +48% | +$67.8K |
|
|
ACTU
3891
Actuate Therapeutics, Inc. Common stock
ACTU
$177M
| $208K | ﹤0.01% |
+27,893
| New | +$208K |
|
3892
Texas Community Bancshares
TCBS
$48.2M
| $208K | ﹤0.01% |
14,026
+1,285
| +10% | +$19K |
|
3893
CXApp
CXAI
$16.3M
| $207K | ﹤0.01% |
123,312
+26,764
| +28% | +$45K |
|
|
ALTS
3894
ALT5 Sigma Corporation Common Stock
ALTS
$501M
| $207K | ﹤0.01% |
116,799
+61,746
| +112% | +$109K |
|
3895
ImmuCell
ICCC
$55.7M
| $206K | ﹤0.01% |
56,660
+962
| +2% | +$3.49K |
|
3896
Lazydays
GORV
$10.3M
| $203K | ﹤0.01% |
4,504
+72
| +2% | +$3.24K |
|
3897
Marker Therapeutics
MRKR
$11M
| $202K | ﹤0.01% |
71,561
+3,319
| +5% | +$9.36K |
|
3898
Sypris Solutions
SYPR
$48.1M
| $201K | ﹤0.01% |
125,793
+20,612
| +20% | +$33K |
|
3899
Fitell Corporation Class A Ordinary Shares
FTEL
$8.57M
| $201K | ﹤0.01% |
12,386
| – | – |
|
|
PVLA
3900
Palvella Therapeutics, Inc. Common Stock
PVLA
$627M
| $201K | ﹤0.01% |
11,981
+1,358
| +13% | +$22.7K |
|